PRescriptiOn PattERns Of Oral Anticoagulants
NCT02366338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148
Last updated 2015-05-21
Summary
Atrial fibrillation is the major cause of acute ischemic stroke. The risk of stroke was shown to decline by oral anticoagulant therapy. The investigators intended to evaluate appropriate use of anticoagulants in non-valvular AF patients.
Conditions
Sponsors & Collaborators
-
Muğla Sıtkı Koçman University
lead OTHER
Principal Investigators
-
Ozcan Basaran · Muğla Sıtkı Koçman University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-08-31
- Primary Completion
- 2014-11-30
- Completion
- 2014-11-30
More Related Trials
-
Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI
NCT04981041 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment Pattern of Oral Anticoagulants (OAC) in Japan
NCT02982863 ·Status: COMPLETED
-
Adherence to New Oral Anticoagulation Therapy in Turkey
NCT02480920 ·Status: COMPLETED
-
Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)
NCT03568916 ·Status: COMPLETED
-
Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
NCT02565693 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Safety in Atrial Fibrillation Patients
NCT00645853 ·Status: COMPLETED ·Phase: PHASE2
-
Therapy With New Oral Anticoagulants
NCT02222090 ·Status: UNKNOWN
-
A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation
NCT05232643 ·Status: RECRUITING
-
Appropriateness of Aspirin Use in Medical Outpatients
NCT03387384 ·Status: UNKNOWN
-
NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH
NCT02998905 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation
NCT03051061 ·Status: UNKNOWN
-
Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)
NCT00623779 ·Status: COMPLETED ·Phase: PHASE2
-
Discontinuation for Oral Anticoagulants in Patients With Atrial Fibrillation
NCT04133545 ·Status: UNKNOWN
-
Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation
NCT02181361 ·Status: COMPLETED
-
Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
NCT02960126 ·Status: UNKNOWN ·Phase: PHASE3
-
Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation
NCT00684307 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Apixaban in Korean Frail Atrial Fibrillation Patient
NCT05773222 ·Status: ACTIVE_NOT_RECRUITING
-
What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
NCT02635230 ·Status: UNKNOWN
-
Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia
NCT01361386 ·Status: COMPLETED
-
APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF
NCT02789917 ·Status: COMPLETED ·Phase: PHASE4
-
Colchicine in Atrial Fibrillation to Prevent Stroke
NCT02282098 ·Status: COMPLETED ·Phase: PHASE3
-
A Prescription Support Tool for Oral Antithrombotic Combinations
NCT03630874 ·Status: COMPLETED ·Phase: NA
-
Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Turkey
NCT03601013 ·Status: COMPLETED
-
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
NCT00412984 ·Status: COMPLETED ·Phase: PHASE3
-
Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
NCT07125417 ·Status: RECRUITING ·Phase: PHASE4